On January 21, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that the Company will present at the MoneyShow Accredited Investors Virtual Expo taking place virtually January 26-28, 2021 (Press release, Genprex, JAN 21, 2021, View Source [SID1234574169]). Genprex’s President and Chief Executive Officer, Rodney Varner, will virtually deliver a company overview, including recent progress made on its upcoming clinical trials, to participating investors on Thursday, January 28.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: MoneyShow Accredited Investors Virtual Expo

Presentation Date: Thursday, January 28

Presentation Time: 12:25 p.m. EST

Registration Link: http://bit.ly/3p0yJOl

The presentation will be available for replay on the Company’s website (www.genprex.com) for a period of time following the conference, and the video will be archived on MoneyShow.com.